Back
AdaptHealth Quote, Financials, Valuation and Earnings
Sponsored
AHCO
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
25
AHCO
AdaptHealth
Last Price:
10.12
Seasonality Move:
3.96%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeAdaptHealth Price Quote
$10.12
-0.03 (-3.62%)
(Updated: November 5, 2024 at 5:12 AM ET)
AdaptHealth Key Stats
Sell
25
AdaptHealth (AHCO)
is a Sell
Day range:
$9.84 - $10.52
52-week range:
$6.37 - $11.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.42
P/B ratio:
0.92%
Volume:
1.1M
Avg. volume:
634K
1-year change:
19.83%
Market cap:
$1.4B
Revenue:
$3.2B
EPS:
$-5.23
How Much Does AdaptHealth Make?
-
How Much Are AdaptHealth's Sales Annually?
AHCO Revenues are $3.2B -
How Much Profit Does AdaptHealth's Make A Year?
AHCO net income is -$678.9M
Is AdaptHealth Growing As A Company?
-
What Is AdaptHealth's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is AdaptHealth's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.44%
AdaptHealth Stock Price Performance
-
Did AdaptHealth Stock Go Up Last Month?
AdaptHealth share price went down by -2.78% last month -
Did AHCO's Share Price Rise Over The Last Year?
AHCO share price rose by 19.83% over the past 1 year
What Is AdaptHealth 52-Week High & Low?
-
What Is AdaptHealth’s 52-Week High Share Price?
AdaptHealth has traded as high as $11.90 over the past 52 weeks -
What Is AdaptHealth’s 52-Week Low Share Price?
AdaptHealth has traded as low as $6.37 over the past 52 weeks
AdaptHealth Price To Free Cash Flow
-
Is AdaptHealth Stock Overvalued?
AdaptHealth is trading at a price to free cash flow ratio of 8.20 -
Is AdaptHealth Stock Undervalued?
AdaptHealth EV to Free Cash Flow ratio is 20.35 -
What Is AdaptHealth’s Price Earnings Growth Ratio?
AHCO PEG ratio is 0.00 -
Is AdaptHealth Trading At A Premium To Earnings?
AdaptHealth EV to EBIT ratio is 0.00
Is It Risky To Buy AdaptHealth?
-
How Much Debt Does AdaptHealth Have?
Total long term debt quarterly is $2.1B -
How Much Cash Does AdaptHealth Have?
Cash and short term investments quarterly total is $69.8M -
What Is AdaptHealth’s Book Value Per Share?
Book value per share is 11.14
Is AdaptHealth Cash Flow Positive?
-
What Is AHCO Cash Flow From Operations?
Cash flow from operations (TTM) is $501.1M -
What Is AdaptHealth’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$139.7M -
What Is AdaptHealth’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$336.7M
AdaptHealth Return On Invested Capital
-
Is Management Doing A Good Job?
AHCO return on invested capital is -18.07% -
What Is AdaptHealth Return On Assets?
ROA measures how assets are converting to revenues and is -14.74% -
What Is AHCO Return On Equity?
ROE is a measure of profitability and is -41.36%
AdaptHealth Earnings Date & Stock Price
-
What Is AdaptHealth's Stock Price Today?
A single share of AHCO can be purchased today for 10.15 -
What Is AdaptHealth’s Stock Symbol?
AdaptHealth trades on the nasdaq under the ticker symbol: AHCO -
When Is AdaptHealth’s Next Earnings Date?
The next quarterly earnings date for AdaptHealth is scheduled on November 5, 2024 -
When Is AHCO's next ex-dividend date?
AdaptHealth's next ex-dividend date is November 5, 2024 -
How To Buy AdaptHealth Stock?
You can buy AdaptHealth shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AdaptHealth Competitors
-
Who Are AdaptHealth's Competitors?
Below is a list of companies who compete with AdaptHealth or are related in some way:
AdaptHealth Dividend Yield
-
What Is AHCO Dividend Yield?
AdaptHealth’s dividend yield currently is 0% -
What Is AdaptHealth’s Payout Ratio?
AdaptHealth’s payout ratio is 0% -
When Did AdaptHealth Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is AdaptHealth’s Dividend Per Share?
AdaptHealth pays a dividend of $0.00 per share
AdaptHealth Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 44.44% | 13.14% |
Revenue: | 1.95% | 0.42% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 12.44 |
Upside from Last Price: | 22.61% |